TERN
Terns Pharmaceuticals, Inc. · Healthcare
Orbimed Advisors LLC bought $8.1M of Terns Pharmaceuticals, Inc.
Director and 10% owner
Bought$8,075,000
$17.00Price
475,000Shares
+26%Stake
What TERN did for a copier
Prices for TERN after this filing aren't in yet.
Orbimed Advisors LLC's record
35 other buys with 3 months of prices since 2016: on average −12.5% against the S&P 500, and 12 of 35 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, Feb 9. Filed Tue, Feb 9, 3:09 PM ET, during the session. Not investment advice.